Literature DB >> 19214118

Epidemiologic characteristics and natural history of HIV-1 natural viral suppressors.

Mohammad M Sajadi1, Neil T Constantine, Dean L Mann, Manhattan Charurat, Elham Dadzan, Peter Kadlecik, Robert R Redfield.   

Abstract

OBJECTIVE: The objective of this study was to detail the epidemiologic characteristics and natural history of HIV-1 natural viral suppressors (NVSs), a cohort of HIV-1-infected individuals who are able to suppress viral replication to undetectable levels in the absence of therapy. DESIGN AND METHODS: HIV-1 patients who met the NVS criteria were enrolled into a prospective study. The incidence and prevalence of NVS were calculated by performing a chart review on all patients seen in 1 clinic in a 10-year period. Cumulative probability of progression-free survival was calculated by Kaplan-Meier product limit method.
RESULTS: Forty individuals enrolled in the study. The median year of diagnosis was 1994, and individuals demonstrated a median 6.7 years of HIV-1 viral suppression and CD4 count of 795 cells per microliter. NVS had an incidence of 1.1% [95% confidence interval (CI), 0.0 to 2.1] and prevalence of 1.5% (95% CI, 0.8 to 2.1). Only 1 patient (2.5%) has progressed. Within the first 10 years for follow-up having met the definition of NVS, 95.1% (95% CI 86.5% to 100%) of the NVS continued to control their viral loads to undetectable levels.
CONCLUSIONS: The NVS cohort has demonstrated remarkable stability and a low rate of progression over many years. Detailed evaluations of viral-host immune regulatory factors associated with persistent HIV-1 natural viral suppression, and loss of such suppression, has the potential to provide important new insight in HIV pathogenesis and future immune regulatory targeted preventive and therapeutic research.

Entities:  

Mesh:

Year:  2009        PMID: 19214118      PMCID: PMC2697612          DOI: 10.1097/QAI.0b013e3181945f1e

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  22 in total

1.  Can we really identify HIV-1 long-term nonprogressors?

Authors:  Sandro Vento; Massimiliano Lanzafame; Marina Malena; Giulia Tositti; Francesca Cainelli; Ercole Concia; Giorgio Masiero
Journal:  J Acquir Immune Defic Syndr       Date:  2004-09-01       Impact factor: 3.731

2.  Biased G-to-A hypermutation in HIV-1 proviral DNA from a long-term non-progressor.

Authors:  Min Wei; Hui Xing; Kunxue Hong; Hailong Huang; Haili Tang; Guangming Qin; Yiming Shao
Journal:  AIDS       Date:  2004-09-03       Impact factor: 4.177

3.  In vitro activation of HIV RNA expression in peripheral blood lymphocytes as a marker to predict the stability of non-progressive status in long-term survivors.

Authors:  A R Garbuglia; R Salvi; A Di Caro; G Cappiello; F Montella; F Di Sora; O Recchia; F Lauria; A Benedetto
Journal:  AIDS       Date:  1996-01       Impact factor: 4.177

4.  HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors.

Authors:  S A Migueles; M S Sabbaghian; W L Shupert; M P Bettinotti; F M Marincola; L Martino; C W Hallahan; S M Selig; D Schwartz; J Sullivan; M Connors
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-14       Impact factor: 11.205

5.  Studies in subjects with long-term nonprogressive human immunodeficiency virus infection.

Authors:  G Pantaleo; S Menzo; M Vaccarezza; C Graziosi; O J Cohen; J F Demarest; D Montefiori; J M Orenstein; C Fox; L K Schrager
Journal:  N Engl J Med       Date:  1995-01-26       Impact factor: 91.245

6.  Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection.

Authors:  Y Cao; L Qin; L Zhang; J Safrit; D D Ho
Journal:  N Engl J Med       Date:  1995-01-26       Impact factor: 91.245

7.  CD4+ T cell depletion in an untreated HIV type 1-infected human leukocyte antigen-B*5801-positive patient with an undetectable viral load.

Authors:  Adriana Andrade; Justin R Bailey; Jie Xu; Frances H Philp; Thomas C Quinn; Thomas M Williams; Stuart C Ray; David L Thomas; Joel N Blankson
Journal:  Clin Infect Dis       Date:  2008-04-15       Impact factor: 9.079

8.  Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study.

Authors:  M Dean; M Carrington; C Winkler; G A Huttley; M W Smith; R Allikmets; J J Goedert; S P Buchbinder; E Vittinghoff; E Gomperts; S Donfield; D Vlahov; R Kaslow; A Saah; C Rinaldo; R Detels; S J O'Brien
Journal:  Science       Date:  1996-09-27       Impact factor: 47.728

9.  Differences in disease progression in a cohort of long-term non-progressors after more than 16 years of HIV-1 infection.

Authors:  Berta Rodés; Carlos Toro; Ellen Paxinos; Eva Poveda; Manuel Martinez-Padial; José Miguel Benito; Victoria Jimenez; Terri Wrin; Sylvina Bassani; Vincent Soriano
Journal:  AIDS       Date:  2004-05-21       Impact factor: 4.177

10.  CCR5 levels and expression pattern correlate with infectability by macrophage-tropic HIV-1, in vitro.

Authors:  L Wu; W A Paxton; N Kassam; N Ruffing; J B Rottman; N Sullivan; H Choe; J Sodroski; W Newman; R A Koup; C R Mackay
Journal:  J Exp Med       Date:  1997-05-05       Impact factor: 14.307

View more
  45 in total

1.  Control of HIV-1 in elite suppressors despite ongoing replication and evolution in plasma virus.

Authors:  Karen A O'Connell; Timothy P Brennan; Justin R Bailey; Stuart C Ray; Robert F Siliciano; Joel N Blankson
Journal:  J Virol       Date:  2010-05-05       Impact factor: 5.103

2.  Identification of Near-Pan-neutralizing Antibodies against HIV-1 by Deconvolution of Plasma Humoral Responses.

Authors:  Mohammad Mohseni Sajadi; Amir Dashti; Zahra Rikhtegaran Tehrani; William D Tolbert; Michael S Seaman; Xin Ouyang; Neelakshi Gohain; Marzena Pazgier; Dongkyoon Kim; Guy Cavet; Jean Yared; Robert R Redfield; George K Lewis; Anthony L DeVico
Journal:  Cell       Date:  2018-05-03       Impact factor: 41.582

3.  Correlation between circulating HIV-1 RNA and broad HIV-1 neutralizing antibody activity.

Authors:  Mohammad M Sajadi; Yongjun Guan; Anthony L DeVico; Michael S Seaman; Mian Hossain; George K Lewis; Robert R Redfield
Journal:  J Acquir Immune Defic Syndr       Date:  2011-05-01       Impact factor: 3.731

4.  Discordant memory B cell and circulating anti-Env antibody responses in HIV-1 infection.

Authors:  Yongjun Guan; Mohammad M Sajadi; Roberta Kamin-Lewis; Timothy R Fouts; Anthony Dimitrov; Zhixin Zhang; Robert R Redfield; Anthony L DeVico; Robert C Gallo; George K Lewis
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-18       Impact factor: 11.205

5.  Inhibitory potential of subpopulations of CD8+ T cells in HIV-1-infected elite suppressors.

Authors:  Robert W Buckheit; Maria Salgado; Robert F Silciano; Joel N Blankson
Journal:  J Virol       Date:  2012-10-10       Impact factor: 5.103

6.  Chronic immune activation and decreased CD4 cell counts associated with hepatitis C infection in HIV-1 natural viral suppressors.

Authors:  Mohammad M Sajadi; Roopa Pulijala; Robert R Redfield; Rohit Talwani
Journal:  AIDS       Date:  2012-09-24       Impact factor: 4.177

7.  Diverse specificity and effector function among human antibodies to HIV-1 envelope glycoprotein epitopes exposed by CD4 binding.

Authors:  Yongjun Guan; Marzena Pazgier; Mohammad M Sajadi; Roberta Kamin-Lewis; Salma Al-Darmarki; Robin Flinko; Elena Lovo; Xueji Wu; James E Robinson; Michael S Seaman; Timothy R Fouts; Robert C Gallo; Anthony L DeVico; George K Lewis
Journal:  Proc Natl Acad Sci U S A       Date:  2012-12-13       Impact factor: 11.205

8.  Elevated hypermutation levels in HIV-1 natural viral suppressors.

Authors:  Lindsay M Eyzaguirre; Manhattan Charurat; Robert R Redfield; William A Blattner; Jean K Carr; Mohammad M Sajadi
Journal:  Virology       Date:  2013-06-19       Impact factor: 3.616

9.  Natural viral suppressors of HIV-1 have a unique capacity to maintain gammadelta T cells.

Authors:  David J Riedel; Mohammad M Sajadi; Cheryl L Armstrong; Jean-Saville Cummings; Cristiana Cairo; Robert R Redfield; C David Pauza
Journal:  AIDS       Date:  2009-09-24       Impact factor: 4.177

10.  Maintenance of HIV-Specific Memory B-Cell Responses in Elite Controllers Despite Low Viral Burdens.

Authors:  Clarisa M Buckner; Lela Kardava; Xiaozhen Zhang; Kathleen Gittens; J Shawn Justement; Colin Kovacs; Adrian B McDermott; Yuxing Li; Mohammad M Sajadi; Tae-Wook Chun; Anthony S Fauci; Susan Moir
Journal:  J Infect Dis       Date:  2016-04-27       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.